Pharma ingredients insured structure
Marketplace opportunity memo with economics, protections, and due diligence perimeter.
Insured Receivables
Hybrid
Low risk
DD review completed
Target net yield
10.9%
Expected net investor return under current structure.
Allocation volume
$4.1M
Total allocation need required to complete marketplace matching.
Tenor
128 days
Expected cycle from allocation close to settlement release.
Minimum ticket
$40,000
Minimum admissible allocation for participation.
Opportunity overview
- Exporter
- NovaLife API (India)
- Buyer
- Germany pharma distributor
- Commodity
- Machinery & equipment
- Corridor
- LATAM — Asia
- Model
- Insured Receivables
- Settlement rail
- Hybrid
- Investor access
- Institutional only
- Documents available
- Data room by request
Risk and protections
- Insurance coverage (Required) applied per corridor policy.
- Escrow mechanism (Mandatory) enforced for settlement protection.
- Counterparty and jurisdiction checks completed before opening allocation.
- Document registry enforces versioning and due diligence disclosure rules.
DD review completed
Economics and protections
- Target net yield of 10.9% disclosed in the current term sheet.
- Insurance wrap covers credit risk up to policy cap; residual retained by investor.
- Allocation remains subject to investor eligibility (Institutional only) and corridor policy.
Due diligence readiness
01Commercial packCore contract, buyer summary, and requested funding memo available.
02Legal packInsured Receivables memo and primary legal structure disclosed.
03ProtectionsInsurance (Required), escrow (Mandatory), and monitoring contours specified.
Route and corridor map
LATAM — Asia
Mode: Route validated in due diligence packETA: Transit plan under review
OriginIndiaExporter-side dispatch and first-mile preparation.
Planned corridorLATAM — AsiaCore route, customs, or bonded transit checkpoint.
DestinationGermanyBuyer-side delivery and settlement trigger location.
OriginIndiaExporter-side dispatch and first-mile preparation.
RouteLATAM — AsiaCore corridor, customs, or bonded transit checkpoint.
DestinationGermanyBuyer-side delivery and settlement trigger location.
Open deals show the planned export corridor before final logistics operators and milestone events are locked in.
Participants
01ExporterNovaLife API (India)
02BuyerGermany pharma distributor
03Settlement railHybrid
Telemetry and operator feed
01RouteOperational route available once execution begins.
02CarrierAssigned at execution activation.
03TelemetryIoT / milestone events appear in active mode.
Timeline and events
01Pre-checkCounterparties, country corridor, and product flow are screened.
02ReadinessDocument set validated and remediation notes attached.
03StructuringInsured Receivables structure, rail contour, and settlement waterfall are fixed.
04AllocationDocument set under review; remediation notes may be attached.
Execution and settlement
- Fees, reserves, and waterfall logic follow approved deal terms.
- Capital deployment and settlement state change only on approved events.
- Residual release follows dispute and reserve rules.
Due diligence documents
| Document | Room | Status | Version |
|---|---|---|---|
| Term sheet | Due diligence | Draft | Draft |
| Commercial pack | Commercial | Pending | Draft |
| Additional evidence | Disclosure | Pending | Draft |